UPDATE: Catalyst Pharma Notes Topline Results For Investigator-Sponsored Phase IIb Study Evaluating Firdapse Were Previously Disclosed; Says Full Results Of Safety, Efficacy Now Available Online; Co-Primary, Secondary Endpoints Were Met
Benzinga Newsdesk